0.4% for those younger than 70 years. (p for difference < 0.0001). Most of the patients were 50-70 years old at operation, and in this group of 551 patients, one died, for a hospital mortality of 0.2% (70% CL* 0.02-0.6%). Parametric analysis3 confirms the highly significant relation between age and risk of operation in this experience (p < 0.0005) ( fig. 1 ). We believe this information has important implications concerning the place of this operation in the management of coronary artery disease in persons older than 70 years.
THE BASIC and clinical research of the last 20 years has provided important new information about coronary artery surgery. Yet, important problems remain. Among the questions that must be answered are: What factors in the patient, in the operation and in postoperative care determine the outcome of surgical treatment? Does the operation prolong useful life? Is the operation affordable?
Knowledge About Coronary Artery Surgery Before examining these questions, we shall briefly review some of our knowledge about the surgical treatment of coronary artery disease.
Hospital Mortality
The risk of coronary bypass surgery is low when it is performed under the proper circumstances." 2 This is obviously important, for if hospital mortality for uncomplicated cases is relatively high -for example, 5% -the late results are affected unfavorably.
In discussing hospital mortality from the operation, we must have current information, because continuing improvements in intraoperative techniques have lowered the risks of the operation. For example, we may look at our experience at the University of Alabama Medical Center in 1977. In that year, we performed primary isolated coronary artery bypass grafting in 757 patients. Many of these patients had significant left ventricular dysfunction and very low ejection fractions, since in general only left ventricular dysfunction so severe as to result in the syndrome of right-heart failure is a contraindication in operation. Seven patients died in hospital, for an overall mortality of 0.9% (table 1) .
In our 1977 experience, the risk of the operation was related to age (table 2). Hospital mortality was 20% for patients older than 70 years, compared with 0.4% for those younger than 70 years. (p for difference < 0.0001). Most of the patients were 50-70 years old at operation, and in this group of 551 patients, one died, for a hospital mortality of 0.2% (70% CL* 0.02-0.6%). Parametric analysis3 confirms the highly significant relation between age and risk of operation in this experience (p < 0.0005) ( fig. 1 ). We believe this information has important implications concerning the place of this operation in the management of coronary artery disease in persons older than 70 years.
These data include all types of patients. This must be ascertained in any surgical report. The Veterans Administration Cooperative Study, for example, includes Qnly patients with chronic stable angina pectoris. 4 Complete revascularization (grafting to all stenosed or obstructed coronary arterial trunks and branches 1 mm or more in internal diameter) is usually possible and can be accomplished without increasing the hospital mortality. The trends from [1970] [1971] [1972] [1973] [1974] [1975] [1976] in 2405 patients at our institution ( fig. 2) show that the number of grafts (or distal anastomoses) has increased while hospital mortality has decreased. In 1977 the average number of distal anastomosis per patient was 3.4, and the hospital mortality 0.9%. In 1977, only 5% of the patients had just one distal anastomosis. In contrast, 47% of the patients had four or more distal anastomoses ( Complete revascularization has been stimulated by data published by several centers, including the Cleveland Clinic8 and the Mayo Clinic,9 that indicate that the completeness of revascularization is directly correlated with the probability of the patient's being asymptomatic after the operation. No 7, DECEMBER 1979 The degree of left ventricular damage already imposed by the coronary atherosclerosis has been shown to affect profoundly the natural history of persons with coronary artery disease, independent of. the number of coronary arterial branches with significant stenotic lesions. 18 Another important variable is the method of protecting the myocardium during the period of cardiac ischemia that is an inherent part of most operations for coronary artery bypass grafting. Intensive research has refined greatly our knowledge of these matters, with an important impact on the results of coronary artery bypass grafting. Myocardial preservation is directly related to the incidence and extent of perioperative myocardial infarction, which in turn has an important effect on both the hospital mortality and long-term results of operation.
Most studies of the efficacy of surgical vs medical treatment for coronary artery disease in prolonging useful life have compared surgical treatment with nonsurgical treatment. Often, the implication has been that the latter is really the natural history of the disease, which seems unlikely. The VA Cooperative Study has raised the question whether the results of medical treatment are changing and are better today than [5] [6] [7] [8] [9] [10] years ago, the period that is the source of much of the so-called control data against which surgical treatment is tested. Whether or not this is true, it emphasizes the potential unreliability of this method of evaluation in providing valuable information. survival of patients undergoing this operation with the survival of the population as a whole taken from life tables. This avoids using as the control medically treated patients, who constitute a subset of persons that is itself subject to change in long-term survival because of changing methods and intensity of medical treatment.
We have evaluated some of our own data in this way. For each subset of patients, an age/sex/racematched life table was constructed from data from the 1974 U.S. Life Tables from the Department of Health, Education, and Welfare. 22 The survival of the subset was compared with its matched life table, which is of course a stable reference point. Such an analysis indicates that once the patient with single-vessel disease becomes a hospital survivor, his life expectancy is the same as that of the age/sex/race matched general population ( fig. 3) . Patients with two-vessel disease have a shorter life expectancy to 5 years than the matched general population, but the difference is not great (fig. 4) . The 5-year life expectancy of patients who undergo surgery for three-vessel disease is less favorable than that of the matched general population, but by only about 6% at 5 years ( fig. 5 ). The late results in surgically treated patients with left main disease who have survived the early postoperative period are similar to those in three-vessel disease ( fig. 6) . Figure 7 is a plot of medically treated patients with three-vessel disease compared with the matched general population. The actuarial data on the surgical series include all categories of patients. In contrast, the VA Cooperative Study is highly selected, containing only patients with chronic stable angina pectoris. That may be one reason for the survival in that study being better than in the other three studies also shown at 4 years. At 4 years, the survival of the surgical patients in all categories was 4% less than that of the 1, 1111-1,   li..l,li,l.1,1,.'.11,.1,11 . years, compared with that of the age matched general population (all patients in the VA study were assumed to be males; their race was not known). The 4-year survivalfigures for medically treated patients reported by Burggraf, 20 Webster24 and Oberman"8 are also shown. No 7, DECEMBER 1979 among the three groups. The 5-year survival of these three groups is significantly less than that of the matched general population, but the differences are not great.
Is the Operation Affordable?
This also is a complex problem, and the answer depends upon both the resources of the patient or group or nation in question and the costs involved in the operation.
Many types of cardiac surgery are more expensive than coronary artery bypass grafting, including surgery for certain kinds of congenital heart disease, the neurosurgical treatment of certain intracranial processes, certain complex operations on the hand, renal transplantation and so forth. In fact, the discussion of affordability of coronary artery bypass grafting arises primarily because of the potentially large number of patients who might require the operation rather than from the inherent costs of the operation itself.
Research has already made the coronary artery surgery more affordable by making it more perfect and nontraumatic, so the patient can recover more quickly and thus less expensively. Most patients who undergo coronary artery bypass grafting in our unit now require an endotracheal tube and a ventilator for only about 6 hours after the operation, and they leave the costly surgical intensive care unit the morning after the operation. About the only complex, and thus costly, intervention that may be required after surgery is the intra-aortic balloon. This was required in only nine (1.2%, CL 0.8%-1.7%) of the 757 patients we operated on in 1977. The postoperative stay in the hospital for the 757 patients was a mean value of 8.98 ± 2.631 (SD) days. Thus, the need for expensive in-hospital care is not very different for patients who undergo coronary artery bypass grafting than for those who undergo such commonplace procedures as gastrectomy and pneumonectomy, and considerably less than for those who have a hip replacement or renal transplant.
True evaluation of the costs of surgical intervention compared with those of years of medical treatment would be interesting. Even the costs to the individual and to society of no treatment, an option our society could consider, might be as great as those of surgical treatment.
These problems must be examined. Rhetoric, premature public announcements and sweeping generalizations can only delay our true understanding of these complex problems.
